Olfen Hydrożel (Diclofenac Sodium)

Diclofenac sodium, the active ingredient in Olfen Hydrożel, is a non‑steroidal anti‑inflammatory drug presented as a topical hydrogel for dermal use. It is indicated for the relief of pain and inflammation associated with musculoskeletal conditions such as sprains, strains and osteoarthritis in adults.

GNH USA supplies Olfen Hydrożel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diclofenac sodium is a NSAID that reduces inflammation and pain in the musculoskeletal system. - Osteoarthritis: helps relieve joint pain and improve mobility. - Acute sprain or strain: reduces local inflammation and pain. - Post‑operative pain: provides topical analgesia after minor surgical procedures.

Adverse reactions may occur with topical diclofenac use.

Common Side Effects: - Skin irritation: redness, itching or burning at the application site. - Dryness: mild peeling or flaking of the skin. - Pruritus: localized itching. - Erythema: mild redness of the treated area.

Serious or Rare Side Effects: - Contact dermatitis: severe allergic skin reaction. - Systemic NSAID effects: gastrointestinal discomfort, headache or dizziness. - Liver enzyme elevation: abnormal liver function tests. - Renal impairment: reduced kidney function in susceptible individuals.

When using Olfen Hydrożel, follow these safety guidelines: - Contraindications: avoid if known allergy to diclofenac or other NSAIDs. - Application area: limit to intact skin and avoid mucous membranes. - Duration of use: do not exceed the recommended treatment period without medical advice. - Concomitant NSAIDs: avoid using other topical or oral NSAIDs simultaneously. - Systemic conditions: use with caution in patients with cardiovascular, renal or hepatic disease. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture and direct sunlight.

Diclofenac sodium may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Anticoagulants: increased risk of bleeding. - Lithium: elevated lithium serum levels. - Methotrexate: enhanced methotrexate toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible reduction in renal function. - Diuretics: heightened risk of renal impairment. - Corticosteroids: additive gastrointestinal irritation. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding risk.